Accurate discrimination of Barrett's esophagus and esophageal adenocarcinoma using a quantitative three-tiered algorithm and multimarker real-time reverse transcription-PCR

Clinical Cancer Research

Volumn 11, Issue 6, 2005, Pages 2205-2214

  Mitas, Michael ^a   Almeida, Jonas S ^b   Mikhitarian, Kaidi ^a   Gillanders, William E ^a   Lewin, David N ^a   Spyropoulos, Demetri D ^a   Hoover, Loretta ^a   Graham, Amanda ^a   Glenn, Tammy ^b   King, Peter ^b   Cole, David J ^a   Hawes, Robert ^b   Reed, Carolyn E ^a   Hoffman, Brenda J ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ENDOTHELIAL CELL GROWTH FACTOR; ENDOTHELIAL CELL GROWTH FACTOR 1; EPITHELIAL CELL ADHESION MOLECULE; MARKER; PROTEIN; RNA; SECRETED PROTEIN ACIDIC CYSTEINE RICH PROTEIN; SMALL BREAST EPITHELIAL MUCIN PROTEIN; TETRASPAN 1 PROTEIN; TREFOIL FACTOR 1 PROTEIN; UNCLASSIFIED DRUG;

ACCURACY; ALGORITHM; ARTICLE; ASSAY; BARRETT ESOPHAGUS; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS; ESOPHAGUS CARCINOMA; GENE; GENE EXPRESSION; GENETIC MARKER; HUMAN; HUMAN TISSUE; MONITORING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLE; SCORING SYSTEM; SENSITIVITY ANALYSIS; SQUAMOUS CELL CARCINOMA; THREE TIERED ALGORITHM; TISSUE;

ADENOCARCINOMA; ADOLESCENT; ALGORITHMS; BARRETT ESOPHAGUS; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 20144387999     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-1091     Document Type: Article

References (47)

1. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-9.
2. Levine DS. Management of dysplasia in the columnar-lined esophagus. Gastroenterol Clin North Am 1997;26:613-34.
3. Overholt BF. Results of photodynamic therapy in Barrett's esophagus: a review. Can J Gastroenterol 1999;13:393-6.
4. Falk GW. Barrett's esophagus. Gastroenterology 2002;122:1569-91.
5. Montgomery E, Bronner MP, Goldblum JR, et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol 2001;32:368-78.
6. Montgomery E, Goldblum JR, Greenson JK, et al. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study. Hum Pathol 2001;32:379-88.
7. Sharma P. Controversies in Barrett's esophagus: management of high grade dysplasia. Semin Gastrointest Dis 2001;12:26-32.
8. Romagnoli R, Collard JM, Gutschow C, Yamusah N, Salizzoni M. Outcomes of dysplasia arising in Barrett's esophagus: a dynamic view. J Am Coll Surg 2003;197:365-71.
9. Chalasani N, Wo JM, Waring JP. Racial differences in the histology, location, and risk factors of esophageal cancer. J Clin Gastroenterol 1998;26:11-3.
10. Comission SCDoHE. Columbia, 2001.
11. Mitas M, Mikhitarian K, Walters C, et al. Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int J Cancer 2001;93:162-71.
12. Mitas M, Mikhitarian K, Hoover L, et al. Prostate-specific ets (PSE) factor: a novel marker for the detection of metastatic breast cancer in axillary lymph nodes. Br J Cancer 2002;86:899-905.
13. Mitas M, Cole DJ, Hoover L, et al. Real-time RT-PCR Detects KS1/4 mRNA in mediastinal lymph nodes from patients with non-small cell lung cancer. Clin Chem 2003;49:312-5.
14. Almeida JS. Predictive non-linear modeling of complex data by artificial neural networks. Curr Opin Biotechnol 2002;13:72-6.
15. Mueller M, Wagner CL, Annibale DJ, et al. Web-based prediction of extubation outcome in premature infants on mechanical ventilation using an artificial neural network. Proc AMIA Symp 2003:945.
16. Van De Bovenkamp JH, Korteland-Van Male AM, Warson C, et al. Gastric-type mucin and TFF-peptide expression in Barrett's oesophagus is disturbed during increased expression of MUC2. Histopathology 2003;42:555-65.
17. Nie SN, Qian XM, Wu XH, et al. Role of TFF in healing of stress-induced gastric lesions. World J Gastroenterol 2003;9:1772-6.
18. 2+-relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray. Oncogene, 2004;23:1291-9.
19. Brabender J, Lord RV, Metzger R, et al. Differential SPARC mRNA expression in Barrett's oesophagus. Br J Cancer 2003;89:1508-12.
20. Dimmler A, Brabletz T, Hlubek F, et al. Transcription of sonic hedgehog, a potential factor for gastric morphogenesis and gastric mucosa maintenance, is up-regulated in acidic conditions. Lab Invest 2003;83:1829-37.
21. Berman DM, Karhadkar SS, Maitra A, et al. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 2003;425:846-51.
22. Nishimaki H, Kasai K, Kozaki K, et al. A role of activated Sonic hedgehog signaling for the cellular proliferation of oral squamous cell carcinoma cell line. Biochem Biophys Res Commun 2004;314:313-20.
23. Latza U, Niedobitek G, Schwarting R, Nekarda H, Stein H. Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial. J Clin Pathol 1990;43:213-9.
24. De Leij L, Helrich W, Stein R Mattes MJ. SCLC-cluster-2 antibodies detect the pancarcinoma/epithelial glycoprotein EGP-2. Int J Cancer Suppl 1994;8:60-3.
25. Maxwell P. Carcinoembryonic antigen: cell adhesion molecule and useful diagnostic marker. Br J Biomed Sci 1999;56:209-14.
26. Oettgen P, Finger E, Sun Z, et al. PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression. J Biol Chem 2000;275:1216-25.
27. Ghadersohi A, Sood AK. Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumors and is a candidate breast tumor marker and a breast tumor antigen. Clin Cancer Res 2001;7:2731-8.
28. Bera TK, Zimonjic DB, Popescu NC, et al. POTE, a highly homologous gene family located on numerous chromosomes and expressed in prostate, ovary, testis, placenta, and prostate cancer. Proc Natl Acad Sci U S A 2002;99:16975-80.
29. Zehentner BK, Dillon DC, Jiang Y, et al. Application of a multigene reverse transcription-PCR assay for detection of mammaglobin and complementary transcribed genes in breast cancer lymph nodes. Clin Chem 2002;48:1225-31.
30. Flejou JF, Paraf F, Muzeau F, et al. Expression of c-erbB-2 oncogene product in Barrett's adenocarcinoma: pathological and prognostic correlations. J Clin Pathol 1994;47:23-6.
31. Miksicek RJ, Myal Y, Watson PH, et al. Identification of a novel breast- and salivary gland-specific, mucin-like gene strongly expressed in normal and tumor human mammary epithelium. Cancer Res 2002;62:2736-40.
32. Henderson AR. Assessing test accuracy and its clinical consequences: a primer for receiver operating characteristic curve analysis. Ann Clin Biochem 1993;30:521-39.
33. Swets JA. Measuring the accuracy of diagnostic systems. Science 1988;240:1285-93.
34. Sanchez P, Hernandez AM, Stecca B, et al. Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling. Proc Natl Acad Sci U S A 2004.
35. Qualtrough D, Buda A, Gaffield W, Williams AC, Paraskeva C. Hedgehog signalling in colorectal tumour cells: induction of apoptosis with cyclopamine treatment. Int J Cancer 2004;110:831-7.
36. Thayer SP, di Magliano MP, Heiser PW, et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003;425:851-6.
37. Brabender J, Marjoram P, Salonga D, et al. A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus. Oncogene 2004;23:4780-8.
38. Mikhitarian K, Reott S, Hoover L, et al. Enhanced detection of RNA from paraffin-embedded tissue using a panel of truncated gene-specific primers for reverse transcription. Biotechniques 2004;36:474-8.
39. MacLennan AJ, Orringer MBBeer DG. Identification of intestinal-type Barrett's metaplasia by using the intestine-specific protein villin and esophageal brush cytology. Mol Carcinog 1999;24:137-43.
40. Went PT, Lugli A, Meier S, et al. Frequent EpCam protein expression in human carcinomas. Hum Pathol 2004;35:122-8.
41. Kumble S, Omary MB, Fajardo LF. Triadafilopoulos G. Multifocal heterogeneity in villin and Ep-CAM expression in Barrett's esophagus. Int J Cancer 1996;66:48-54.
42. Martin IG, Cutts SG, Birbeck K, Gray S, Quirke P. Expression of the 17-1A antigen in gastric and gastro-oesophageal junction adenocarcinomas: a potential immunotherapeutic target? J Clin Pathol 1999;52:701-4.
43. Vizoso FJ, Fagilde MC, Corte MD, et al. Cytosolic levels of an estrogen-induced breast cancer-associated peptide (TFF1/pS2) in colorectal cancer: clinical significance and relationship with steroid receptors. Int J Biol Markers 2003;18:301-10.
44. Bonkhoff H, Stein U, Welter C, Remberger K. Differential expression of the pS2 protein in the human prostate and prostate cancer: association with premalignant changes and neuroendocrine differentiation. Hum Pathol 1995;26:824-8.
45. Cronin M, Pho M, Dutta D, et al. Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay. Am J Pathol 2004;164:35-42.
46. Dennis P, Edwards EA, Liss SN, Fulthorpe R. Monitoring gene expression in mixed microbial communities by using DNA microarrays. Appl Environ Microbiol 2003;69:769-78.
47. van den Brink GR, Hardwick JC, Tytgat GN, et al. Sonic hedgehog regulates gastric gland morphogenesis in man and mouse. Gastroenterology 2001;121:317-28.